Among the expert panel and the participants in the Delphi attitudes survey, the frequency of review with individuals with T2D on insulin therapy was consistent with the NICE guidelines for the management of T2D in adults, with 65.7% of respondents indicating that reviews were held at least every 6 months (Table S3). This evidence concerns the gene INS and type 2 diabetes mellitus.